Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 16Nausea 13Neoplasms 5Breast Neoplasms 3Rectal Neoplasms 2Hematologic Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms, Male 2Weight Loss 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Pancreatic Neoplasms 1Nausea With Vomiting Chemotherapy-Induced 1Multiple Myeloma 1Melanoma 1Lymphoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Inflammatory Breast Neoplasms 1Hematologic Diseases 1Glioma 1Gallbladder Neoplasms 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Anus Neoplasms 1

Interventions

Palonosetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Nausea With Vomiting Chemotherapy-Induced × Palonosetron × Clear all
NCT04592198 2025-03-24

Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting

Xiamen LP Pharmaceutical Co., Ltd

Phase 2 Completed
22 enrolled 8 charts

Nausea With Vomiting Chemotherapy-Induced

Data powered by HemOnc (CC BY 4.0) Colophon âš¡